Nurix Therapeutics reports $87.2 million Q1 loss amid drug trials

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MRVL

Go back to Nurix Therapeutics reports $87.2 million Q1 loss amid drug trials
(NASDAQ: NRIX) Delayed: 16.95 -0.03 (0.18%)
Previous Close $16.98    52 Week High $ 
Open $17.16    52 Week Low $ 
Day High $17.88    P/E N/A 
Day Low $16.93    EPS $ 
Volume 2,560,597